Literature DB >> 17768347

Crystallization and preliminary X-ray structural studies of a Melan-A pMHC-TCR complex.

Fang Yuan1, Theonie Georgiou, Theresa Hillon, Emma Gostick, David A Price, Andrew K Sewell, Ruth Moysey, Jessie Gavarret, Annelise Vuidepot, Malkit Sami, John I Bell, George F Gao, Pierre J Rizkallah, Bent K Jakobsen.   

Abstract

Melanocytes are specialized pigmented cells that are found in all healthy skin tissue. In certain individuals, diseased melanocytes can form malignant tumours, melanomas, which cause the majority of skin-cancer-related deaths. The melanoma-associated antigenic peptides are presented on cell surfaces via the class I major histocompatibility complex (MHC). Among the melanoma-associated antigens, the melanoma self-antigen A/melanoma antigen recognized by T cells (Melan-A/MART-1) has attracted attention because of its wide expression in primary and metastatic melanomas. Here, a preliminary X-ray crystal structural study of a soluble cognate T-cell receptor (TCR) in complex with a pMHC presenting the Melan-A peptide (ELAGIGILTV) is reported. The TCR and pMHC were refolded, purified and mixed together to form complexes, which were crystallized using the sitting-drop vapour-diffusion method. Single TCR-pMHC complex crystals were cryocooled and used for data collection. Diffraction data showed that these crystals belonged to space group P4(1)/P4(3), with unit-cell parameters a = b = 120.4, c = 81.6 A. A complete data set was collected to 3.1 A and the structure is currently being analysed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17768347      PMCID: PMC2376329          DOI: 10.1107/S1744309107037244

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  14 in total

1.  Stable, soluble T-cell receptor molecules for crystallization and therapeutics.

Authors:  Jonathan M Boulter; Meir Glick; Penio T Todorov; Emma Baston; Malkit Sami; Pierre Rizkallah; Bent K Jakobsen
Journal:  Protein Eng       Date:  2003-09

2.  UVA-induced modification of catalase charge properties in the epidermis is correlated with the skin phototype.

Authors:  Vittoria Maresca; Enrica Flori; Stefania Briganti; Emanuela Camera; Muriel Cario-André; Alain Taïeb; Mauro Picardo
Journal:  J Invest Dermatol       Date:  2006-01       Impact factor: 8.551

3.  Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues.

Authors:  D Valmori; J F Fonteneau; C M Lizana; N Gervois; D Liénard; D Rimoldi; V Jongeneel; F Jotereau; J C Cerottini; P Romero
Journal:  J Immunol       Date:  1998-02-15       Impact factor: 5.422

Review 4.  Melanoma antigens and their recognition by T cells.

Authors:  G Parmiani
Journal:  Keio J Med       Date:  2001-06

5.  Crystal structures of two closely related but antigenically distinct HLA-A2/melanocyte-melanoma tumor-antigen peptide complexes.

Authors:  P Sliz; O Michielin; J C Cerottini; I Luescher; P Romero; M Karplus; D C Wiley
Journal:  J Immunol       Date:  2001-09-15       Impact factor: 5.422

6.  A major histocompatibility complex-peptide-restricted antibody and t cell receptor molecules recognize their target by distinct binding modes: crystal structure of human leukocyte antigen (HLA)-A1-MAGE-A1 in complex with FAB-HYB3.

Authors:  Martin Hülsmeyer; Patrick Chames; Roman C Hillig; Robyn L Stanfield; Gerhard Held; Pierre G Coulie; Claudia Alings; Gabriele Wille; Wolfram Saenger; Barbara Uchanska-Ziegler; Hennie R Hoogenboom; Andreas Ziegler
Journal:  J Biol Chem       Date:  2004-11-10       Impact factor: 5.157

7.  A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.

Authors:  P van der Bruggen; C Traversari; P Chomez; C Lurquin; E De Plaen; B Van den Eynde; A Knuth; T Boon
Journal:  Science       Date:  1991-12-13       Impact factor: 47.728

8.  Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor.

Authors:  Y Kawakami; S Eliyahu; C H Delgado; P F Robbins; L Rivoltini; S L Topalian; T Miki; S A Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

9.  Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection.

Authors:  Y Kawakami; S Eliyahu; C H Delgado; P F Robbins; K Sakaguchi; E Appella; J R Yannelli; G J Adema; T Miki; S A Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

10.  A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.

Authors:  P G Coulie; V Brichard; A Van Pel; T Wölfel; J Schneider; C Traversari; S Mattei; E De Plaen; C Lurquin; J P Szikora; J C Renauld; T Boon
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

View more
  3 in total

1.  Germ line-governed recognition of a cancer epitope by an immunodominant human T-cell receptor.

Authors:  David K Cole; Fang Yuan; Pierre J Rizkallah; John J Miles; Emma Gostick; David A Price; George F Gao; Bent K Jakobsen; Andrew K Sewell
Journal:  J Biol Chem       Date:  2009-07-15       Impact factor: 5.157

Review 2.  Antigen-specific blocking of CD4-specific immunological synapse formation using BPI and current therapies for autoimmune diseases.

Authors:  Prakash Manikwar; Paul Kiptoo; Ahmed H Badawi; Barlas Büyüktimkin; Teruna J Siahaan
Journal:  Med Res Rev       Date:  2011-03-23       Impact factor: 12.944

3.  Identification of a public CDR3 motif and a biased utilization of T-cell receptor V beta and J beta chains in HLA-A2/Melan-A-specific T-cell clonotypes of melanoma patients.

Authors:  Federico Serana; Alessandra Sottini; Luigi Caimi; Belinda Palermo; Pier Giorgio Natali; Paola Nisticò; Luisa Imberti
Journal:  J Transl Med       Date:  2009-03-24       Impact factor: 5.531

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.